In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii

In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli

(2010) M. G. P. Page et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug‐ResistantAcinetobacter baumannii:An Emerging Pathogen among Older Adults in Community Hospitals and Nursing Homes

(2010) D. M. Sengstock et al.   CLINICAL INFECTIOUS DISEASES

Siderophores as drug delivery agents: application of the “Trojan Horse” strategy

(2009) Ute Möllmann et al.   BIOMETALS

Pandrug Resistance (PDR), Extensive Drug Resistance (XDR), and Multidrug Resistance (MDR) among Gram‐Negative Bacilli: Need for International Harmonization in Terminology

(2008) Matthew E. Falagas et al.   CLINICAL INFECTIOUS DISEASES

Why are we afraid of Acinetobacter baumannii?

(2008) Federico Perez et al.   Expert Review of Anti-Infective Therapy

Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology

(2008) T. A. Russo et al.   INFECTION AND IMMUNITY